Cinven looks to take Synlab private as Covid boost falters

Frankfurt-listed Synlab could be about to be taken private following a non-binding full takeover offer earlier this week. With its full year results released yesterday and facing questions about its plans, HBI asks market experts what they think of the move.

Top Doctors raises $13m to boost growth

Top Doctors, the third biggest doctor-booking platform in private healthcare after EU-based Doctolib and global player DocPlanner, has raised $13m to improve its digital tools and grow in key sectors. HBI chats with Alberto E. Porciani, CEO of Top Doctors to find out more.

AXA partners with Microsoft and buys providers

AXA and Microsoft have launched an ambitious and innovative digital healthcare platform that is already live in Italy and Germany with other major European countries to follow over the next six months.

Domiciliary care growth rockets

This week we look at the growing domiciliary care market's largest players by revenue, with this interactive table.

Under-fire Dentix may have a new suitor

Spanish dental chain Dentix has a new suitor, according to the Spanish press. The company has had a troubled history of late, heading into voluntary administration in April following a reported series of failed sales processes, including to Advent and KKR.

Mexico’s private hospitals enlisted in fight after occupancy plummets

Occupancy in Mexico's private hospital sector has plummeted due to COVID-19, a local operator tells HBI. Much of that spare capacity will go towards treating public non-COVID patients after a deal was struck with the government in an effort to prepare for an incoming wave of infected patients.

Booking data shows outpatient has all but stopped

Patient footfall for outpatient care across the world has all but stopped. Exclusive data from DocPlanner shows which specialities have seen the biggest drop in appointments booked and where telemedicine is really picking up some of the slack. We assess this against outpatient volumes in Singapore during SARS to see when it might pick up.

Mexican clinic boosts low-income patients by monetising quality

With the help of a results-based financing mechanism, Mexico's largest specialised diabetes provider Clínicas del Azúcar has doubled its number of patients from the poorest segments of society and tells HBI it can now double the locations for potential clinics. We speak to its CEO and the co-creator of 'social impact incentives' about how to monetise extra value in impact investing.

Find Us